Benzodiazepines

Publication Title: 
The Journal of Clinical Psychiatry

OBJECTIVE: To review the evidence for treating anxiety in patients with bipolar disorder. DATA SOURCES: A literature search from 1950 to week 1 of August 2009 was conducted via OVID and the National Institutes of Health's clinical trials online databases. Search terms included anxiety, anxiety disorders, bipolar disorder, panic disorder, generalized anxiety disorder, social phobia, social anxiety, obsessive compulsive disorder, specific phobia, posttraumatic stress disorder, and treatment. Reference lists of identified articles were also searched.

Author(s): 
Rakofsky, Jeffrey J.
Dunlop, Boadie W.
Publication Title: 
Psychiatric Genetics

BACKGROUND: Although there is indirect evidence that the effects of antipsychotic drugs may involve modulation of dopamine transmission, their mechanism of action is poorly understood. We hypothesized that antipsychotic drugs mediate their effects by epigenetic modulation. Here, we tested the effect of an antipsychotic, olanzapine, on the DNA methylation status of genes following chronic treatment using rat-specific methylation arrays.

Author(s): 
Melka, Melkaye G.
Rajakumar, Nagalingam
O'Reilly, Richard
Singh, Shiva M.
Publication Title: 
Experimental Neurology

A hexanucleotide repeat expansion residing within the C9ORF72 gene represents the most common known cause of amyotrophic lateral sclerosis (ALS) and places the disease among a growing family of repeat expansion disorders. The presence of RNA foci, repeat-associated translation products, and sequestration of RNA binding proteins suggests that toxic RNA gain-of-function contributes to pathology while C9ORF72 haploinsufficiency may be an additional pathological factor.

Author(s): 
Zeier, Zane
Esanov, Rustam
Belle, Kinsley C.
Volmar, Claude-Henry
Johnstone, Andrea L.
Halley, Paul
DeRosa, Brooke A.
Khoury, Nathalie
van Blitterswijk, Marka
Rademakers, Rosa
Albert, Jeffrey
Brothers, Shaun P.
Wuu, Joanne
Dykxhoorn, Derek M.
Benatar, Michael
Wahlestedt, Claes
Publication Title: 
European Journal of Pharmacology

The conditions under which prolongation of halothane-induced sleeping time in the mouse may be used as a test for centrally acting drugs are described. The test can be recommended for its practical advantages over methods using barbiturates to induce hypnosis; due cognizance must be taken of a diurnal variation in the response of mice to halothane. To assess the usefulness of the test the effects of amphetamine, chlorpromazine, histamine, morphine, nikethamide, pentobarbitone and SKF 525A have been investigated.

Author(s): 
Chambers, D. M.
Jefferson, G. C.
Ruddick, C. A.
Publication Title: 
Pharmacology, Biochemistry, and Behavior

Clinical trials have indicated that buspirone (Buspar) is effective in the treatment of anxiety with efficacy and dosage comparable to diazepam. Until recently it has been thought that antianxiety drugs must alter benzodiazepine receptor binding in vitro. However, buspirone lacks any structural similarity to te benzodiazepines and does not interact with the benzodiazepine/gamma-aminobutyric acid (GABA) axis.

Author(s): 
Taylor, D. P.
Riblet, L. A.
Stanton, H. C.
Eison, A. S.
Eison, M. S.
Temple, D. L.
Publication Title: 
L'Encéphale

Diazepam, clorazepate and flunitrazepam are used to premedicate , to anesthetize and after the intervention. Anxiolysis , sedation, hypnosis, muscle relaxation, amnesia and seizure prevention justified their employment. They have few side effects. Anesthesiologist just have to be careful of their long-acting effects as for ambulatory anaesthesia.

Author(s): 
Lepresle, E.
Debras, C.
Publication Title: 
Arzneimittel-Forschung

A new series of 2,3-cyclopentano-3,4-dihydro-4-spirocyclopentano-1,5-benzodi azepine which are substituted in 5-position with beta-N-heterocycloethyl or gamma-N-heterocyclo-n-propyl groups have been synthesized and evaluated for their CNS depressant activity including anticonvulsant, analgesic and pentobarbital induced hypnosis. These compounds were also investigated for their ability to inhibit in vitro succinate dehydrogenase (SDH). In most of the compounds an appreciable CNS depressant activity has been found to be associated with the compounds possessing good SDH inhibitory activity.

Author(s): 
Dhasmana, A.
Mehrotra, S.
Gupta, T. K.
Bhargava, K. P.
Parmar, S. S.
Barthwal, J. P.
Publication Title: 
Psychopharmacology. Supplementum

Over the last 20 years standardized techniques have been employed for the investigation of intravenous hypnotics, psychotropic and neuroleptic drugs. Sleep has been studied with the help of EEG measures and side-effects have been evaluated by psychometric tests. The EEG is a proven parameter with regard to dosage determination and as objective means to find sleep-inducing quantities of drugs. By means of vigilosomnograms we have established dose-effect curves and have made comparisons between related drugs in the form of equivalence studies.

Author(s): 
Doenicke, A.
Publication Title: 
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica

The behavioral effects of 450191-S and its metabolites were investigated in mice, rats, cats and rhesus monkeys, and they were compared with those of related benzodiazepines (BDZ) such as diazepam and nitrazepam. Oral administration of 450191-S consistently caused sedation without excitability in mice and rats, and it was only 1/2 to 1/266 as potent as the BDZ in producing motor incoordination as assessed by traction, rotarod performance and inclined screen tests in mice, induced much less ataxia in cats and monkeys, and inhibited respiration in anesthetized cats.

Author(s): 
Yamamoto, K.
Hirose, K.
Matsushita, A.
Yoshimura, K.
Sawada, T.
Eigyo, M.
Jyoyama, H.
Fujita, A.
Matsubara, K.
Tsukinoki, Y.
Publication Title: 
Anesthesiology

Midazolam is an imidazobenzodiazepine with unique properties when compared with other benzodiazepines. It is water soluble in its acid formulation but is highly lipid soluble in vivo. Midazolam also has a relatively rapid onset of action and high metabolic clearance when compared with other benzodiazepines. The drug produces reliable hypnosis, amnesia, and antianxiety effects when administered orally, intramuscularly, or intravenously.

Author(s): 
Reves, J. G.
Fragen, R. J.
Vinik, H. R.
Greenblatt, D. J.

Pages

Subscribe to RSS - Benzodiazepines